front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |review |
The eligibility
criteria are seen here and it should be noted that there were two cohorts. One was
designed to look at the incidence of any complications, particularly retinopathy, that is
the primary cohort, and another to examine the effect of glycemic control on the early
progression of complications, the secondary cohort.
|